Literature DB >> 7619998

Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS.

R C Kalayjian1, Z Toossi, J F Tomashefski, J T Carey, J A Ross, J W Tomford, R J Blinkhorn.   

Abstract

We reviewed the clinical, radiographic, and histologic features of nine patients with AIDS and pulmonary disease due to Mycobacterium avium complex (MAC). Pulmonary MAC disease was defined by (1) the isolation of MAC from two or more lower respiratory tract specimens or from a single lung biopsy sample, (2) an infiltrate revealed by chest radiography, and (3) the absence of other identified pulmonary pathogens or malignancies. Pulmonary MAC disease was present in five (2.5%) of 200 patients with disseminated MAC infection and in four additional patients without evidence of dissemination, as assessed by blood culture. The median CD4 cell count at the time of presentation was 90/microL. Pulmonary MAC disease was the initial AIDS-defining infection in five patients and presented within a median of 5 months after the initial infection in four patients. Radiographic patterns for these nine patients included consolidating or nodular infiltrates and cavitation. The histopathology of pulmonary MAC disease was characterized by granulomatous inflammation, often associated with necrosis and few evident organisms. The conditions of all patients treated with multidrug regimens clinically improved.

Entities:  

Mesh:

Year:  1995        PMID: 7619998     DOI: 10.1093/clinids/20.5.1186

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

Review 1.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Clinical and prognostic importance of serotyping Mycobacterium avium-Mycobacterium intracellulare complex isolates in human immunodeficiency virus-negative patients.

Authors:  Ryoji Maekura; Yoshinari Okuda; Atsusi Hirotani; Seigo Kitada; Touru Hiraga; Kenji Yoshimura; Ikuya Yano; Kazuo Kobayashi; Masami Ito
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation.

Authors:  W Chalermskulrat; N Sood; I P Neuringer; T M Hecker; L Chang; M P Rivera; L J Paradowski; R M Aris
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

4.  Investigation of mycobacterial colonisation and invasion of the respiratory mucosa.

Authors:  A M Middleton; M V Chadwick; A G Nicholson; A Dewar; C Feldman; R Wilson
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

Review 5.  Tuberculosis and HIV infection: a review.

Authors:  D Schürmann; S D Nightingale; F Bergmann; B Ruf
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 7.455

6.  Role of gamma delta T cells in immunopathology of pulmonary Mycobacterium avium infection in mice.

Authors:  B M Saunders; A A Frank; A M Cooper; I M Orme
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 7.  Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?

Authors:  Christoph G Lange; Ian J Woolley; Reinhard H Brodt
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Comparative radiological features of disseminated disease due to Mycobacterium tuberculosis vs non-tuberculosis mycobacteria among AIDS patients in Brazil.

Authors:  Rodrigo P dos Santos; Karin L Scheid; Denise Mc Willers; Luciano Z Goldani
Journal:  BMC Infect Dis       Date:  2008-02-29       Impact factor: 3.090

Review 9.  Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases.

Authors:  Surendra K Sharma; Vishwanath Upadhyay
Journal:  Indian J Med Res       Date:  2020-09       Impact factor: 2.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.